Blog
RSS FeedPosted by Michael Wonder on 20 May 2019
Korean Government to reduce biopharmaceutical approval period to half
20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...
Posted by Michael Wonder on 14 May 2019
Helping Canadians get faster access to the prescription drugs they need to live healthier lives
13 May 2019 - Government of Canada consults on new approach to fast-track the review of treatments for serious, rare ...
Posted by Michael Wonder on 10 May 2019
Speed up cancer funding, ALP told
11 May 2019 - The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer ...
Posted by Michael Wonder on 23 Apr 2019
Canadians will wait longer for new medicines if Health Canada gets its way
23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new ...
Posted by Michael Wonder on 23 Apr 2019
Additional embargo period following revised CDEC recommendations
17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...
Posted by Michael Wonder on 15 Apr 2019
PHARMAC's early access scheme needs work - Prime Minister Jacinda Ardern
16 April 2019 - Prime Minister Jacinda Ardern admits work needs to be done on PHARMAC's early access scheme, but ...
Posted by Michael Wonder on 04 Apr 2019
Daiichi Sankyo provides update on ongoing FDA review for quizartinib for treatment of patients with relapsed/refractory FLT3-ITD AML
4 April 2019 - Daiichi Sankyo today announced that the U.S. FDA has extended the review period for the new ...
Posted by Michael Wonder on 03 Apr 2019
Drug companies call out PHARMAC for lack of transparency and timeliness
3 April 2019 - Two of the world's largest pharmaceutical companies say New Zealand is lagging behind other countries when ...
Posted by Michael Wonder on 27 Mar 2019
Whanganui District Health Board says small number of patients affects cancer treatment wait time results
28 March 2019 - Whanganui District Health Board failed to meet the national faster cancer treatment target in January. ...
Posted by Michael Wonder on 26 Mar 2019
Cancer Society critical of PHARMAC saying they 'lack accountability, lack transparency, are slow'
26 March 2019 - PHARMAC "lack accountability, lack transparency, are slow", in delivering pharmaceutical drugs to New Zealanders who need ...
Posted by Michael Wonder on 20 Mar 2019
Biosimilar approval and adoption in the U.S. needs to be expedited
20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...
Posted by Michael Wonder on 20 Mar 2019
The shadow of Brexit on speed of access
20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union. ...
Posted by Michael Wonder on 15 Mar 2019
Karyopharm announces FDA extension of review period for selinexor new drug application
14 March 2019 - PDUFA action date extended by three months to July 6, 2019. ...
Posted by Michael Wonder on 14 Mar 2019
One in four cancer patients wait two months for treatment, as NHS performance hits record low
14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...
Posted by Michael Wonder on 13 Mar 2019
Bavarian Nordic announces FDA delay in the review of the biologics license application for MVA-BN smallpox vaccine
11 March 2019 - Bavarian Nordic today announced that it has received information from the U.S. FDA that the review ...